ArticleOncoTargets and therapy2019

Tanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway.

Rui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.